KE3235A - Medicaments for treating hypertension - Google Patents

Medicaments for treating hypertension

Info

Publication number
KE3235A
KE3235A KE3235A KE323582A KE3235A KE 3235 A KE3235 A KE 3235A KE 3235 A KE3235 A KE 3235A KE 323582 A KE323582 A KE 323582A KE 3235 A KE3235 A KE 3235A
Authority
KE
Kenya
Prior art keywords
medicaments
treating hypertension
hypertension
treating
Prior art date
Application number
KE3235A
Other languages
English (en)
Inventor
P Horovitz Zola
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KE3235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of KE3235A publication Critical patent/KE3235A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KE3235A 1977-12-27 1982-09-14 Medicaments for treating hypertension KE3235A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
KE3235A true KE3235A (en) 1982-11-05

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3235A KE3235A (en) 1977-12-27 1982-09-14 Medicaments for treating hypertension

Country Status (30)

Country Link
JP (1) JPS54110333A (ja)
AR (1) AR230378A1 (ja)
AU (1) AU526239B2 (ja)
BE (1) BE873092A (ja)
CA (1) CA1120400A (ja)
CH (1) CH642542A5 (ja)
DE (1) DE2854316C3 (ja)
DK (1) DK578778A (ja)
EG (1) EG14178A (ja)
FI (1) FI783991A (ja)
FR (1) FR2413089A1 (ja)
GB (1) GB2010675B (ja)
GR (1) GR72951B (ja)
HK (1) HK45483A (ja)
HU (1) HU178747B (ja)
IE (1) IE48306B1 (ja)
IL (1) IL56281A (ja)
IT (1) IT1202811B (ja)
KE (1) KE3235A (ja)
LU (1) LU80709A1 (ja)
MY (2) MY8300240A (ja)
NL (2) NL192870C (ja)
NO (1) NO784357L (ja)
NZ (1) NZ189159A (ja)
PH (1) PH22111A (ja)
PL (1) PL212188A1 (ja)
PT (1) PT68983A (ja)
SE (1) SE445173B (ja)
SG (1) SG41482G (ja)
ZA (1) ZA786948B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
GR72951B (ja) 1984-01-17
HU178747B (en) 1982-06-28
ZA786948B (en) 1980-04-30
NO784357L (no) 1979-06-28
FR2413089B1 (ja) 1980-12-26
HK45483A (en) 1983-10-28
JPS54110333A (en) 1979-08-29
NL7812164A (nl) 1979-06-29
JPS647045B2 (ja) 1989-02-07
NZ189159A (en) 1984-12-14
FI783991A (fi) 1979-06-28
FR2413089A1 (fr) 1979-07-27
IT1202811B (it) 1989-02-09
NL980017I1 (nl) 1998-07-01
NL192870B (nl) 1997-12-01
AU526239B2 (en) 1982-12-23
MY102991A (en) 1993-03-31
DE2854316A1 (de) 1979-07-05
LU80709A1 (de) 1979-04-13
PT68983A (en) 1979-01-01
BE873092A (fr) 1979-06-27
GB2010675A (en) 1979-07-04
GB2010675B (en) 1982-06-16
SG41482G (en) 1985-01-11
MY8300240A (en) 1983-12-31
IE782413L (en) 1979-06-27
CA1120400A (en) 1982-03-23
DE2854316C2 (ja) 1989-08-10
DK578778A (da) 1979-06-28
PH22111A (en) 1988-06-01
IL56281A (en) 1983-05-15
EG14178A (en) 1984-06-30
PL212188A1 (ja) 1980-02-11
IT7831266A0 (it) 1978-12-22
AU4204178A (en) 1979-07-05
IE48306B1 (en) 1984-12-12
SE7813277L (sv) 1979-06-28
IL56281A0 (en) 1979-03-12
DE2854316C3 (de) 1994-12-22
NL192870C (nl) 1998-04-02
CH642542A5 (de) 1984-04-30
AR230378A1 (es) 1984-04-30
SE445173B (sv) 1986-06-09

Similar Documents

Publication Publication Date Title
JPS53146427A (en) Set for construction
JPS5317572A (en) Improvement for treating substances
JPS5474386A (en) Controller
KE3235A (en) Medicaments for treating hypertension
GB2011163B (en) Image-intensifier apparatus
JPS5444740A (en) Controller
GB2002637B (en) Device for treating teeth
JPS52120131A (en) Treating composition for rercholesterol disease
PH14956A (en) Trans-broparestrol based therapeutic
GB1554602A (en) Isulated chips
GB2003475B (en) Process for 2-chlorosulphinylazetidin-4-ones
JPS5424627A (en) Removinggagent for phtoresist
JPS53127835A (en) Treating agent for burn
JPS5413465A (en) Twoostage treatment for effluent
JPS5416489A (en) Antidyeing treatment
GB2002231B (en) Hypertension treating agent
JPS53148660A (en) Controller
JPS53117521A (en) Controller
JPS5449348A (en) Set for *inarizushi*
JPS53119301A (en) Apparatus for treating chip
IL54182A0 (en) Process for 3-beta-aminoazetiden-2-ones
JPS53116362A (en) Process for 16alphaamethylsteroid
JPS5464625A (en) Drug for treating piles
JPS53127179A (en) Feed
GB1554484A (en) Reduction process